We studied the impact of p53 on TRAIL sensitivity in xenografted ALL cells using the recently described experimental setting of RNA interference after amplification of primary childhood ALL cells in NOD/SCID mice [3,4,7,21-24]. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.